查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828131

2025年全球植入式心律管理设备市场报告

Implantable Cardiac Rhythm Management Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，植入式心律管理设备市场稳定成长，市场规模从2024年的170.6亿美元成长至2025年的177亿美元，复合年增长率为3.8%。预测期内的成长归因于人口老化、心律不整发病率上升、意识提升和教育措施的推进、医疗基础设施的建设以及医疗支出的增加。

预计未来几年植入式心律管理设备市场将强劲成长，2029年将达到231.5亿美元，复合年增长率为6.9%。预测期内的成长可归因于向无导线设备的转变、远端病患监测、对心臟衰竭管理的日益重视、新兴市场的日益普及以及研发合作。预测期内的主要趋势包括生物可吸收技术的兴起、人工智慧 (AI) 的整合、技术进步、远端监测与远端医疗的整合、无导线起搏器的进步、无线充电和电源管理。

植入式心律管理装置是一种小型、电池供电的装置，透过手术植入体内并连接到心臟，在维持和管理心律方面发挥重要作用。

植入式心律管理设备类别的主要设备包括心臟再同步治疗 (CRT)、去心房颤动和心律调节器。心臟再同步治疗 (CRT) 是一种专门针对严重心律问题的治疗方法。这些设备在医院、心臟中心和其他医疗机构中用于治疗各种疾病，包括心搏过缓心搏过速。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、加强标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供植入式心律管理设备市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的植入式心律管理设备细分市场、市场趋势和商业机会，为您提供在植入式心律管理设备行业取得成功所需的数据。本植入式心律管理设备市场研究报告提供了您所需的所有信息，并详细分析了该行业的现状和未来情况。

我们预测未来五年该市场将成长6.9%，较先前预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会对美国造成直接影响，例如对来自墨西哥和丹麦等主要地区的长寿命锂电池和生物相容性铅绝缘材料征收关税，从而可能导致起搏器/去心房颤动植入推迟，并增加心臟护理成本。此外，由于贸易紧张局势加剧和限制措施增加，互惠关税以及对全球经济和贸易的负面影响，这种影响也将更为广泛地显现。

心臟病患病率的上升预计将显着推动植入式心律管理设备市场的成长。心臟病是指影响心臟和血管的疾病。植入式心律管理设备旨在透过心臟再同步改善收缩功能并在危及生命的快速心室心律不整期间恢復正常心律，从而帮助心臟衰竭或左心室功能减退的患者。因此，心臟病盛行率的上升将推动对这些设备的需求。例如，英国心血管研究慈善机构英国心臟基金会的数据显示，截至2024年9月，英国约有760万人患有心臟和循环系统疾病。其中，约有400万男性和360万名女性患有这些疾病，约占英国所有死亡人数的27%，每年超过17万人死亡。因此，心臟病盛行率的上升是推动植入式心律管理设备市场成长的关键因素。

预计未来几年，老龄化人口的成长将显着推动植入式心律管理设备市场的成长。老化是指人口中很大一部分正在老化，并且人口平均年龄不断增加的人口群体。植入式心律管理设备经常被这类人群用于解决和管理各种心臟相关问题。例如，2024 年 1 月，美国非营利组织人口问题实验室预测，65 岁及以上的美国数量将从 2022 年的 5,800 万人增加 47% 到 2050 年的 8,200 万人。此外，预计同期该年龄层在总人口中的比例将从 17% 增加到 23%。因此，老化人口的扩大是推动植入式心律管理设备市场成长的主要因素。

技术进步是植入式心律管理设备市场的一大趋势，主要企业专注于开发创新技术以维持其市场地位。美国公司 Rhythm Management Group PLLC 于 2022 年 4 月宣布推出 RhythmSynergy。 RhythmSynergy 是一个技术平台，利用机器学习为使用植入式心臟设备和穿戴式装置进行远端监控的患者提供及时的临床洞察。该平台透过将临床知识与机器学习技术相结合，简化了审查流程，使患者数据的审查、共用和分析变得更加简单。

植入式心律管理设备市场的主要企业正优先推出创新产品，例如植入式心臟去心房颤动。 2023年10月，法国製造商MicroPort CRM推出了ULYS植入式心臟整流去颤器（ICD）和INVICTA去心房颤动植入式设备。 ULYS ICD整合了最尖端科技、AutoMRI功能和PARAD心律不整辨识演算法，最大限度地降低了功耗。 INVICTA去心房颤动导线持续侦测来自右心室的电讯号，并在心率过低时进行心律调节治疗。

2022年8月，美国医疗科技公司Medtronic完成了对Affera的收购，收购金额未揭露。此次收购使Medtronic能够使用Affera Prism-1TM心臟定位和导航平台，该平台支援Medtronic的治疗导管和一系列竞争技术。 Affera是一家总部位于美国的医疗科技公司，专门生产用于治疗心律不整患者的心臟定位和导航系统。

植入式心律管理设备市场的主要企业包括 Schiller AG、Medtronic plc、Abbott Laboratories、Boston Scientific Corporation、Koninklijke Philips NV、Zoll Medical Corporation、BIoTronik Ltd.、MicroPort Scientific Corporation、Abiomed Inc.、Nihon Kohden Corporation、Japan Lifeline Co. Ltd.、Lepu Medical Technology Co. Ltd.、LivaNova PLC、深圳迈瑞生物医学电子股份有限公司、Progetti Srl、Edwards Lifesciences Corporation、Cardiac Science Corporation、Bardy Diagnostics Inc.、北京迪玛克医疗技术有限公司、iRhythm Technologies Inc.、Impulse Dynamics plc. 和 VytronUS Inc.。

2024 年，北美是植入式心律管理设备市场最大的地区。植入式心律管理设备市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

植入式心律管理设备市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

植入式心律管理设备市场涵盖无导线心律调节器、植入式心臟监视器、心臟导线以及植入式心臟整流去颤器(S-ICD) 的销售。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式心律管理设备：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球植入式心律管理设备市场：成长率分析
  • 全球植入式心律管理设备市场表现：规模与成长，2019-2024
  • 全球植入式心律管理设备市场预测：规模与成长，2024-2029年，2034年
  • 全球植入式心律管理设备：总目标市场（TAM）

第六章 市场细分

  • 全球植入式心律管理设备市场（按设备、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 心臟再同步治疗（CRT）
  • 去心房颤动
  • 起搏器
  • 全球植入式心律管理设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 心搏过缓
  • 心搏过速
  • 其他的
  • 全球植入式心律管理设备市场（依最终用途、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专门的心臟中心
  • 其他的
  • 全球植入式心律管理设备市场：心臟再同步治疗 (CRT) 细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • CRT-P（心律调节器）
  • CRT-D（去心房颤动）
  • 全球植入式心律管理设备市场：去心房颤动细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 植入式心臟整流去颤器（ICD）
  • 皮下植入式心臟整流去颤器（S-ICD）
  • 全球植入式心律管理设备市场：心律调节器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔起搏器
  • 双腔起搏器
  • 双心室节律器

第七章 区域和国家分析

  • 全球植入式心律管理设备市场：2019-2024 年、2024-2029 年及 2034 年区域表现与预测
  • 全球植入式心律管理设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 植入式心律管理设备市场：竞争格局
  • 植入式心律管理设备市场：公司简介
    • Schiller AG
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Koninklijke Philips NV

第31章：其他领先和创新企业

  • Zoll Medical Corporation
  • BIoTronik Ltd.
  • MicroPort Scientific Corporation
  • Abiomed Inc
  • Nihon Kohden Corporation
  • Japan Lifeline Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • LivaNova PLC
  • Shenzhen Mindray Biomedical Electronics Co. Ltd
  • Progetti Srl
  • Edwards Lifesciences Corporation
  • Cardiac Science Corporation
  • Bardy Diagnostics Inc.
  • Beijing Demax Medical Technology Co. Ltd
  • iRhythm Technologies Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年植入式心律管理设备市场：提供新机会的国家
  • 2029年植入式心律管理设备市场：细分市场将带来新机会
  • 2029年植入式心律管理设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24222u

Implantable cardiac rhythm management devices are small battery-operated devices that are surgically inserted inside the body and connected to the heart, playing a crucial role in maintaining and managing heart rhythm.

The primary devices in the category of implantable cardiac rhythm management devices include cardiac resynchronization therapy, defibrillators, and pacemakers. Cardiac resynchronization therapy (CRT) is a specialized treatment designed for severe cardiac rhythm issues. These devices find applications in various conditions such as bradycardia, tachycardia, and others, and are utilized in hospitals, specialty cardiac centers, and other medical settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable cardiac rhythm management device market research report is one of a series of new reports from The Business Research Company that provides implantable cardiac rhythm management device market statistics, including implantable cardiac rhythm management device industry global market size, regional shares, competitors with implantable cardiac rhythm management device market share, detailed implantable cardiac rhythm management device market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardiac rhythm management device industry. This implantable cardiac rhythm management device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardiac rhythm management device market size has grown steadily in recent years. It will grow from $17.06 billion in 2024 to $17.7 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to the aging population, increasing incidence of cardiac arrhythmias, awareness and education initiatives, healthcare infrastructure development, and rising healthcare expenditure.

The implantable cardiac rhythm management device market size is expected to see strong growth in the next few years. It will grow to $23.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to a shift towards leadless devices, remote patient monitoring, a focus on heart failure management, increased adoption in emerging markets, and collaborations for research and development. Major trends in the forecast period include the emergence of bioresorbable technologies, integration of artificial intelligence (AI), advancements in technology, remote monitoring and telemedicine integration, advancements in leadless pacemakers, wireless charging, and power management.

The forecast of 6.9% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on long-life lithium batteries and biocompatible lead insulation materials, sourced from key regions such as Mexico and Denmark, which could lead to postponed pacemaker/defibrillator implants and higher costs for cardiac care.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cardiac disorders is anticipated to significantly enhance the growth of the implantable cardiac rhythm management devices market. Cardiac disorders refer to conditions that impact the heart or blood vessels. Implantable cardiac rhythm management devices are designed to assist patients with heart failure and diminished left ventricular function by improving systolic function through the resynchronization of heart contractions and restoring normal rhythm during life-threatening rapid ventricular arrhythmias. As a result, the growing prevalence of cardiac disorders will drive demand for these devices. For instance, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million individuals in the UK are affected by heart and circulatory diseases. This includes about 4 million men and 3.6 million women living with these conditions, which account for roughly 27% of all deaths in the UK, translating to over 170,000 fatalities each year, or about 480 deaths per day-equivalent to one death every three minutes. Therefore, the increasing prevalence of cardiac disorders is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

The growing aging population is anticipated to significantly drive the growth of the implantable cardiac rhythm management devices market in the coming years. An aging population refers to a demographic trend where a significant portion of a country's citizens are becoming older, leading to a higher average age among its residents. Implantable cardiac rhythm management devices are frequently utilized within this demographic to address and manage various heart-related issues. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Additionally, this age group's proportion of the total population is expected to increase from 17% to 23% over the same period. Consequently, the expanding aging population is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

Technological advancement stands out as a prominent trend in the implantable cardiac rhythm management devices market, with major companies focusing on developing innovative technologies to maintain their market position. Rhythm Management Group PLLC, a US-based company, introduced RhythmSynergy in April 2022, a technology platform that utilizes machine learning to deliver timely clinical insights for patients monitored remotely with implantable cardiac devices and wearable devices. This platform streamlines the review processes by combining clinical knowledge and machine learning technologies, making it simpler to review, share, and analyze patient data.

Major companies in the implantable cardiac rhythm management devices market prioritize the launch of innovative products such as implantable cardiac defibrillators. In October 2023, MicroPort CRM, a France-based manufacturer, launched the ULYS Implantable Cardioverter Defibrillator (ICDs) and INVICTA defibrillation implantable devices. The ULYS ICD integrates cutting-edge technology with minimal energy consumption, featuring the AutoMRI function and PARAD arrhythmia discrimination algorithm. The INVICTA defibrillation lead consistently senses electrical signals from the right ventricle, providing pacing therapy if the heart rate is too low.

In August 2022, Medtronic, a US-based medical technology company, completed the acquisition of Affera Inc. for an undisclosed amount. This acquisition grants Medtronic access to the Affera Prism-1TM cardiac mapping and navigation platform, compatible with both Medtronic therapeutic catheters and various competing technologies. Affera Inc., a US-based medical technology company, specializes in manufacturing cardiac mapping and navigation systems for treating patients with cardiac arrhythmias.

Major companies operating in the implantable cardiac rhythm management device market include Schiller AG, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik Ltd., MicroPort Scientific Corporation, Abiomed Inc, Nihon Kohden Corporation, Japan Lifeline Co. Ltd., Lepu Medical Technology Co. Ltd., LivaNova PLC, Shenzhen Mindray Biomedical Electronics Co. Ltd, Progetti Srl, Edwards Lifesciences Corporation, Cardiac Science Corporation, Bardy Diagnostics Inc., Beijing Demax Medical Technology Co. Ltd, iRhythm Technologies Inc., Impulse Dynamics plc., VytronUS Inc.

North America was the largest region in the implantable cardiac rhythm management device market in 2024. The regions covered in the implantable cardiac rhythm management device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable cardiac rhythm management device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable cardiac rhythm management devices market consists of sales of the leadless pacemaker, insertable cardiac monitor, cardiac leads, and subcutaneous implantable defibrillator (S-ICD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardiac Rhythm Management Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardiac rhythm management device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardiac rhythm management device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable cardiac rhythm management device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device: Cardiac Resynchronization Therapy; Defibrillators; Pacemakers
  • 2) By Application: Bradycardia; Tachycardia; Other Applications
  • 3) By End-Use: Hospitals; Specialty Cardiac Centers; Other End-Uses
  • Subsegments:
  • 1) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker); CRT-D (Defibrillator)
  • 2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs); Subcutaneous Implantable Defibrillators (S-ICDs)
  • 3) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers
  • Companies Mentioned: Schiller AG; Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik Ltd.; MicroPort Scientific Corporation; Abiomed Inc; Nihon Kohden Corporation; Japan Lifeline Co. Ltd.; Lepu Medical Technology Co. Ltd.; LivaNova PLC; Shenzhen Mindray Biomedical Electronics Co. Ltd; Progetti Srl; Edwards Lifesciences Corporation; Cardiac Science Corporation; Bardy Diagnostics Inc.; Beijing Demax Medical Technology Co. Ltd; iRhythm Technologies Inc.; Impulse Dynamics plc.; VytronUS Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardiac Rhythm Management Device Market Characteristics

3. Implantable Cardiac Rhythm Management Device Market Trends And Strategies

4. Implantable Cardiac Rhythm Management Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Cardiac Rhythm Management Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Cardiac Rhythm Management Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Cardiac Rhythm Management Device Market Growth Rate Analysis
  • 5.4. Global Implantable Cardiac Rhythm Management Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Cardiac Rhythm Management Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Cardiac Rhythm Management Device Total Addressable Market (TAM)

6. Implantable Cardiac Rhythm Management Device Market Segmentation

  • 6.1. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Resynchronization Therapy
  • Defibrillators
  • Pacemakers
  • 6.2. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradycardia
  • Tachycardia
  • Other Applications
  • 6.3. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Cardiac Centers
  • Other End-Uses
  • 6.4. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-P (Pacemaker)
  • CRT-D (Defibrillator)
  • 6.5. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Cardioverter Defibrillators (ICDs)
  • Subcutaneous Implantable Defibrillators (S-ICDs)
  • 6.6. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers

7. Implantable Cardiac Rhythm Management Device Market Regional And Country Analysis

  • 7.1. Global Implantable Cardiac Rhythm Management Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Cardiac Rhythm Management Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardiac Rhythm Management Device Market

  • 8.1. Asia-Pacific Implantable Cardiac Rhythm Management Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardiac Rhythm Management Device Market

  • 9.1. China Implantable Cardiac Rhythm Management Device Market Overview
  • 9.2. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardiac Rhythm Management Device Market

  • 10.1. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardiac Rhythm Management Device Market

  • 11.1. Japan Implantable Cardiac Rhythm Management Device Market Overview
  • 11.2. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardiac Rhythm Management Device Market

  • 12.1. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardiac Rhythm Management Device Market

  • 13.1. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardiac Rhythm Management Device Market

  • 14.1. South Korea Implantable Cardiac Rhythm Management Device Market Overview
  • 14.2. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardiac Rhythm Management Device Market

  • 15.1. Western Europe Implantable Cardiac Rhythm Management Device Market Overview
  • 15.2. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardiac Rhythm Management Device Market

  • 16.1. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardiac Rhythm Management Device Market

  • 17.1. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardiac Rhythm Management Device Market

  • 18.1. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardiac Rhythm Management Device Market

  • 19.1. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardiac Rhythm Management Device Market

  • 20.1. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardiac Rhythm Management Device Market

  • 21.1. Eastern Europe Implantable Cardiac Rhythm Management Device Market Overview
  • 21.2. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardiac Rhythm Management Device Market

  • 22.1. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardiac Rhythm Management Device Market

  • 23.1. North America Implantable Cardiac Rhythm Management Device Market Overview
  • 23.2. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardiac Rhythm Management Device Market

  • 24.1. USA Implantable Cardiac Rhythm Management Device Market Overview
  • 24.2. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardiac Rhythm Management Device Market

  • 25.1. Canada Implantable Cardiac Rhythm Management Device Market Overview
  • 25.2. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardiac Rhythm Management Device Market

  • 26.1. South America Implantable Cardiac Rhythm Management Device Market Overview
  • 26.2. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardiac Rhythm Management Device Market

  • 27.1. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardiac Rhythm Management Device Market

  • 28.1. Middle East Implantable Cardiac Rhythm Management Device Market Overview
  • 28.2. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardiac Rhythm Management Device Market

  • 29.1. Africa Implantable Cardiac Rhythm Management Device Market Overview
  • 29.2. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardiac Rhythm Management Device Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Cardiac Rhythm Management Device Market Competitive Landscape
  • 30.2. Implantable Cardiac Rhythm Management Device Market Company Profiles
    • 30.2.1. Schiller AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardiac Rhythm Management Device Market Other Major And Innovative Companies

  • 31.1. Zoll Medical Corporation
  • 31.2. Biotronik Ltd.
  • 31.3. MicroPort Scientific Corporation
  • 31.4. Abiomed Inc
  • 31.5. Nihon Kohden Corporation
  • 31.6. Japan Lifeline Co. Ltd.
  • 31.7. Lepu Medical Technology Co. Ltd.
  • 31.8. LivaNova PLC
  • 31.9. Shenzhen Mindray Biomedical Electronics Co. Ltd
  • 31.10. Progetti Srl
  • 31.11. Edwards Lifesciences Corporation
  • 31.12. Cardiac Science Corporation
  • 31.13. Bardy Diagnostics Inc.
  • 31.14. Beijing Demax Medical Technology Co. Ltd
  • 31.15. iRhythm Technologies Inc.

32. Global Implantable Cardiac Rhythm Management Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardiac Rhythm Management Device Market

34. Recent Developments In The Implantable Cardiac Rhythm Management Device Market

35. Implantable Cardiac Rhythm Management Device Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Cardiac Rhythm Management Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Cardiac Rhythm Management Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Cardiac Rhythm Management Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer